Kailera Therapeutics (KAIL:NASDAQ) Targets Record‑Setting Momentum Following $625M IPO Kailera Therapeutics’ US$625M IPO — the largest U.S. biopharma listing on record — continues to draw strong market attention as investors …
DAYFILE:
